NCT03983993View on ClinicalTrials.gov

Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

May 17, 2023

Study Completion Date

October 31, 2025

Conditions
Advanced Microsatellite Stable Colorectal CarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaMicrosatellite StableRAS Wild TypeStage IV Colorectal Cancer AJCC v8MSI-H Colorectal Cancer
Interventions
DRUG

Niraparib

Given PO

BIOLOGICAL

Panitumumab

Given IV

Trial Locations (3)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER